Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)

This study includes the strategies of the main local companies in the period 2003-2018: Grupo Roemmers, Grupo Bago, Elea, Casasco, Baliarda and Raffo. It seeks to explain the process by which these corporations transformed the Argentine pharmaceutical industry, displacing multinational companies, an...

Descripción completa

Detalles Bibliográficos
Autor principal:	Naspleda, Federico Daniel
Formato:	Artículo publishedVersion
Lenguaje:	Español
Publicado:	UBA–FCE–CEEED / IIEP BAIRES–UBA-CONICET 2023
Acceso en línea:	https://ojs.economicas.uba.ar/index.php/CEEED/article/view/2418 https://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=anuario&d=2418_oai
Aporte de:	Repositorio Digital de la Universidad de Buenos Aires (UBA) de Universidad de Buenos Aires

id	I28-R145-2418_oai
record_format	dspace
spelling	I28-R145-2418_oai2025-02-10 Naspleda, Federico Daniel 2023-05-15 This study includes the strategies of the main local companies in the period 2003-2018: Grupo Roemmers, Grupo Bago, Elea, Casasco, Baliarda and Raffo. It seeks to explain the process by which these corporations transformed the Argentine pharmaceutical industry, displacing multinational companies, and the limits that their development presents with respect to the Argentine health system. For this, it is evaluated in a novel way, on the one hand, how the changes in the sector worldwide conditioned the form of competition in Argentina. On the other hand, using a descriptive methodology and specific concepts of the subject, the most important strategies carried out by Argentine laboratories at the local and regional level are studied, examining their drug portfolios, commercial agreements, their productive structures, patents in the country, among other things. En este estudio se comprenden las estrategias de las principales empresas locales en el periodo 2003-2018: Grupo Roemmers, Grupo Bagó, Elea, Casasco, Baliarda y Raffo. Se busca explicar el proceso por el cual estas corporaciones transformaron la industria farmacéutica argentina desplazando a las empresas multinacionales, y los límites que presenta su desarrollo respecto al sistema de salud argentino. Para esto se evalúa de manera novedosa, por una parte, como los cambios del sector a nivel mundial condicionaron la forma de competencia en Argentina. Por otra parte, utilizando una metodología descriptiva y conceptos específicos del tema, se estudian las estrategias más importantes llevadas a cabo por los laboratorios argentinos a nivel local y regional, examinando sus porfolios de medicamentos, los acuerdos comerciales, sus estructuras productivas, las patentes en el país, entre otros aspectos. application/pdf https://ojs.economicas.uba.ar/index.php/CEEED/article/view/2418 10.56503/ANUARIO/Nro.19(15)pp.169-212 spa UBA–FCE–CEEED / IIEP BAIRES–UBA-CONICET https://ojs.economicas.uba.ar/index.php/CEEED/article/view/2418/3426 https://ojs.economicas.uba.ar/index.php/CEEED/article/view/2418/3447 Derechos de autor 2023 Anuario Centro de Estudios Económicos de la Empresa y el Desarrollo https://creativecommons.org/licenses/by-nc/4.0/deed.es Anuario Centro de Estudios Económicos de la Empresa y el Desarrollo; No 19 (15): Anuario Junio-Noviembre 2023; 169-212 Anuario Centro de Estudios Económicos de la Empresa y el Desarrollo; Núm. 19 (15): Anuario Junio-Noviembre 2023; 169-212 2545-8299 Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018) Transformación en la industria farmacéutica argentina: del liderazgo de las empresas internacionales Big Pharma al dominio de las corporaciones locales de genéricos de marca (2003-2018) info:ar-repo/semantics/artículo info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/publishedVersion https://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=anuario&d=2418_oai
institution	Universidad de Buenos Aires
institution_str	I-28
repository_str	R-145
collection	Repositorio Digital de la Universidad de Buenos Aires (UBA)
language	Español
orig_language_str_mv	spa
description	This study includes the strategies of the main local companies in the period 2003-2018: Grupo Roemmers, Grupo Bago, Elea, Casasco, Baliarda and Raffo. It seeks to explain the process by which these corporations transformed the Argentine pharmaceutical industry, displacing multinational companies, and the limits that their development presents with respect to the Argentine health system. For this, it is evaluated in a novel way, on the one hand, how the changes in the sector worldwide conditioned the form of competition in Argentina. On the other hand, using a descriptive methodology and specific concepts of the subject, the most important strategies carried out by Argentine laboratories at the local and regional level are studied, examining their drug portfolios, commercial agreements, their productive structures, patents in the country, among other things.
format	Artículo publishedVersion publishedVersion
author	Naspleda, Federico Daniel
spellingShingle	Naspleda, Federico Daniel Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)
author_facet	Naspleda, Federico Daniel
author_sort	Naspleda, Federico Daniel
title	Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)
title_short	Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)
title_full	Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)
title_fullStr	Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)
title_full_unstemmed	Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)
title_sort	transformation in the argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)
publisher	UBA–FCE–CEEED / IIEP BAIRES–UBA-CONICET
publishDate	2023
url	https://ojs.economicas.uba.ar/index.php/CEEED/article/view/2418 https://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=anuario&d=2418_oai
work_keys_str_mv	AT naspledafedericodaniel transformationintheargentinepharmaceuticalindustryfromtheleadershipofinternationalbigpharmacompaniestothedominanceoflocalcorporationsofbrandedgenerics20032018 AT naspledafedericodaniel transformacionenlaindustriafarmaceuticaargentinadelliderazgodelasempresasinternacionalesbigpharmaaldominiodelascorporacioneslocalesdegenericosdemarca20032018
_version_	1825550716065808384

Transformation in the Argentine pharmaceutical industry: from the leadership of international big pharma companies to the dominance of local corporations of branded generics (2003-2018)

Ejemplares similares